Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-23-026127

Director acquired 120,000 shares (option exercise)

  • Director gave up 87,042 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Titterton Lewis H jr · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-27 Exercise or conversion : show line 1 in the form +120,000 $2.58 $309,000 894,070 D
2023-07-27 Shares withheld for taxes : show line 2 in the form −87,042 $3.55 $308,999 807,028 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-27 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −120,000 0 D
Loading xslF345X05/ownership.xml…